Ruth Nussinov Selected Research

Infections

4/2007

Conformational study of the protegrin-1 (PG-1) dimer interaction with lipid bilayers and its effect.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruth Nussinov Research Topics

Disease

84	Neoplasms (Cancer) 05/2024 - 01/2008
35	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 02/2006
11	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 04/2006
6	Inflammation (Inflammations) 11/2023 - 08/2013
6	Amyloid Plaque 10/2014 - 10/2009
5	Neurodevelopmental Disorders 12/2023 - 06/2022
5	Carcinogenesis 01/2022 - 08/2013
5	Breast Neoplasms (Breast Cancer) 02/2021 - 12/2006
5	Parkinson Disease (Parkinson's Disease) 01/2021 - 10/2016
5	Adenocarcinoma 01/2020 - 09/2015
4	Amyloidosis 06/2018 - 06/2003
3	Leukemia 01/2023 - 01/2012
3	Neoplasm Metastasis (Metastasis) 11/2019 - 01/2014
3	Type 2 Diabetes Mellitus (MODY) 09/2018 - 01/2016
3	Lung Neoplasms (Lung Cancer) 10/2016 - 09/2015
3	Memory Disorders (Memory Loss) 10/2014 - 02/2012
3	Down Syndrome (Down's Syndrome) 05/2011 - 08/2009
2	Autistic Disorder (Autism) 12/2023 - 04/2023
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 03/2016
2	Proteostasis Deficiencies 10/2014 - 02/2012
1	Adenocarcinoma of Lung 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	COVID-19 12/2020
1	Multiple Sclerosis 01/2020
1	Substance-Related Disorders (Drug Abuse) 01/2020

Drug/Important Bio-Agent (IBA)

43	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2003
24	Peptides (Polypeptides)IBA 01/2021 - 04/2007
19	Amyloid (Amyloid Fibrils)IBA 01/2021 - 10/2006
12	Protein Isoforms (Isoforms)IBA 12/2023 - 09/2015
10	Calmodulin (Calcium-Dependent Activator Protein)IBA 12/2021 - 09/2015
7	LipidsIBA 12/2023 - 08/2015
6	cysteinyl-arginyl-glutamyl-lysyl-alanylIBA 01/2013 - 07/2008
5	CytokinesIBA 01/2022 - 01/2014
5	Amino Acids FDA Link 01/2021 - 06/2009
5	Ion Channels (Ion Channel)IBA 01/2017 - 10/2009
4	Phosphotransferases (Kinase)IBA 03/2023 - 08/2013
4	CalciumIBA 01/2017 - 12/2009
4	Blood Proteins (Serum Proteins)IBA 01/2013 - 01/2009
3	Monomeric GTP-Binding ProteinsIBA 06/2022 - 01/2016
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 08/2013
3	ras ProteinsIBA 01/2022 - 09/2015
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 07/2016
3	SynucleinsIBA 01/2021 - 10/2016
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2024 - 08/2023
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2023 - 01/2023
2	ChromatinIBA 04/2023 - 01/2020
2	LigandsIBA 01/2023 - 01/2021
2	Interleukin-1 (Interleukin 1)IBA 06/2022 - 02/2014
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 04/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
2	Superoxide Dismutase-1IBA 01/2021 - 03/2016
2	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2020 - 12/2019
2	Aripiprazole (Abilify)FDA Link 01/2020 - 12/2019
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2019 - 01/2008
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 11/2018 - 04/2012
2	Protein Kinases (Protein Kinase)IBA 10/2018 - 08/2013
2	Islet Amyloid PolypeptideIBA 09/2018 - 01/2016
2	SolutionsIBA 10/2017 - 03/2011
2	tau Proteins (tau Protein)IBA 11/2016 - 01/2016
2	polyglutamineIBA 11/2016 - 04/2006
2	ZincIBA 03/2016 - 05/2010
2	FibrinIBA 01/2013 - 10/2010
2	Peptide Hydrolases (Proteases)FDA Link 06/2011 - 06/2009
2	Amyloid beta-PeptidesIBA 04/2010 - 02/2006
1	EnzymesIBA 12/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2023
1	GenieIBA 01/2023
1	Polo-Like Kinase 1IBA 08/2022
1	Nucleic AcidsIBA 01/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022
1	InterferonsIBA 01/2022
1	Mutant Proteins (Protein, Mutant)IBA 12/2021
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2021
1	ErbB Receptors (EGF Receptor)IBA 02/2021
1	IgA receptor (protein B)IBA 02/2021
1	human ERBB2 proteinIBA 02/2021
1	Trastuzumab (Herceptin)FDA Link 02/2021
1	Monoclonal AntibodiesIBA 02/2021
1	Epidermal Growth Factor (EGF)IBA 02/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	cdc42 GTP-Binding ProteinIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	GTP Phosphohydrolases (GTPases)IBA 01/2021
1	SurvivinIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	sepantroniumIBA 01/2021
1	gantenerumabIBA 10/2020
1	crenezumabIBA 10/2020
1	AlpelisibIBA 06/2020
1	Therapeutic UsesIBA 01/2020
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2020
1	Haloperidol (Haldol)FDA LinkGeneric 01/2020

Therapy/Procedure

18	Therapeutics 05/2024 - 03/2011
7	Precision Medicine 01/2022 - 10/2010
3	Immunotherapy 11/2021 - 03/2014